INTRODUCTION Surgical resection of a malignant bone tumor (BT) or soft tissue tumor (STT), with or without prosthetic replacement, carries a high risk of developing postoperative infections. There is limited knowledge on the bacteriological spectrum of these postsurgical infections that necessitate empirical antibiotic therapy. The aim of this study was to analyze the incidence and microbiologi...

TO THE EDITOR—I read with interest the article by Farrin Manian regarding the role of postoperative factors in surgical site infections (SSIs) [1]. I agree with Dr Manian that, although the majority of SSIs are almost certainly determined during surgery, there are definitely factors after the patient leaves the operating room that can lead to infection. Dr Manian cites several references regard...

PURPOSE Thyroglossal duct cysts (TGDC) are the most common head and neck congenital anomalies in children and often present as infected neck masses. The authors reviewed their experience with TGDC to determine if preoperative infection was related to postoperative complications, including recurrence and postoperative infection. METHODS The medical records of 99 patients undergoing excision of...

Surgical site infections (SSIs) are a significant source of morbidity, mortality, and cost associated with small animal surgery. The most well-established strategies to reduce the impact of SSI are preventive, focusing on bolstering host immunity while decreasing wound contamination during surgery. When SSI is identified, the use of consistent definitions and culture-based therapy help to facil...

OBJECTIVE: To determine mortality, morbidity, and costs attributable to surgical-site infections (SSIs) in the 1990s. DESIGN: A matched follow-up study of a cohort of patients with SSI, matched one-to-one with patients without SSI. SETTING: A 415-bed community hospital. STUDY POPULATION: 255 pairs of patients with and without SSI were matched on age, procedure, National Nosocomial Infection Sur...

EVIDENCE DEFINITIONS • Class I: Prospective randomized controlled trial. • Class II: Prospective clinical study or retrospective analysis of reliable data. Includes observational, cohort, prevalence, or case control studies. • Class III: Retrospective study. Includes database or registry reviews, large series of case reports, expert opinion. • Technology assessment: A technology study which doe...

Although surgical site infections (SSIs) occurring after hospital discharge cause substantial morbidity, their epidemiology is not well understood, and methods for routine postdischarge surveillance have not been validated. Inpatient and outpatient surveillance followed 5572 nonobstetric procedures among members of a health maintenance organization with extensive automated records. Records were...

New preliminary data from the U.S. Department of Health and Human Services (HHS) showed a 9 percent decrease in patient injuries in hospitals in 2012 compared with a 2010 baseline, and an 8 percent decrease in Medicare fee-for-service 30-day readmissions.2 The data also showed improvement on a range of measures for health care-associated infections (HAIs) and conditions, including for SSIs. HEN...

Surgical site infections (SSIs) are defined as infections occurring up to 30 days after surgery (or up to one year after surgery in patients receiving implants) and affecting either the incision or deep tissue at the operation site. Despite improvements in prevention, SSIs remain a significant clinical problem as they are associated with substantial mortality and morbidity and impose severe dem...

Despite many attempts to prevent surgical site infections (SSIs), these complications are not uncommon in most hospitals while the precise determination of the burden of these infections in our country has not been performed but crude data in hospitals shows a significant cost of managements. With an estimated 27 million surgical procedures annually, and near 2– 5% rate of SSIs, approximately 3...